VMD
Viemed Healthcare, Inc. Common Shares
SERVICES-MISC HEALTH & ALLIED SERVICES, NEC
Best Medical Devices Stocks 2026 →
VMD Stock Analysis: Buy, Sell, or Hold?
$9.13
+0.15 (+1.67%)
▲
5d:
-9.69%
30d:
-4.99%
90d:
-0.44%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (79%)
Quality Score
44/100
Position
OVERSOLD
30-Day Fair Range
$9.23 – $9.85
Position: OVERSOLD
Forward P/E & Valuation
17.7x
FAIR
vs 15.6x historical avg
Wall Street Target
$12.00
+31.4% upside
Options IV & Volume
44th pct IV
HIGH volume confirmation
Support / Resistance
$8.71 / $10.21
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: VMD shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When VMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$15.70
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$9.75
6.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 15.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: VMD is currently trading at $9.13, which is considered oversold relative to its 30-day fair value range of $9.23 to $9.85. From a valuation perspective, the stock is trading at a premium (Forward PE: 17.7) compared to its historical average (15.6). At these levels, the market is pricing in 4.1% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, VMD is in a strong downtrend. Immediate support is located at $8.71, while resistance sits at $10.21.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $12.00 (+31.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, VMD is in a strong downtrend. Immediate support is located at $8.71, while resistance sits at $10.21.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $12.00 (+31.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$9.23 -
$9.85
Company Quality Score
44/100
(HOLD)
Options IV Signal
44th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
78.5%
Trading Range & Key Levels
30-Day Trading Range
$9.23 -
$9.85
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$1.11
(12.2%)
Support Level
$8.71
Resistance Level
$10.21
Current Trend
Strong Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 44th percentile)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 31.4% below Wall St target ($12.00)
- NEUTRAL: Market pricing in 4.1% annual earnings growth - fairly valued
- WARNING: Composite score 44/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
17.67
Wall Street Target
$12.00
(+31.4%)
Revenue Growth (YoY)
12.2%
Earnings Growth (YoY)
22.2%
Profit Margin
5.0%
Valuation Premium vs History
+4.1% premium
PE vs Historical
17.7 vs 15.6
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.1%
(market-implied from PE analysis)
1-Year Target
$9.50
(+4%)
2-Year Target
$9.89
(+8%)
3-Year Target
$10.30
(+13%)
3-Yr Target (if PE normalizes)
(PE: 18→16)
PE COMPRESSION
$9.09
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 29.2%)
$22.12
(+142%)
Base:
(SPY PE: 17.7, Growth: 29.2%)
$19.68
(+116%)
Bear:
(PE: 15.0, Growth: 29.2%)
$16.73
(+83%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (24x PE), but valuation improves significantly next year (18x PE) as earnings recover.
Trailing PE: 23.63 | Current EPS (TTM): $0.38
Bull Case
$13.43
(+47%)
Analyst growth 36.0%, PE expands to 26.0
Base Case
$12.21
(+34%)
Market implied 36.0%, PE stable at 23.6
Bear Case
$6.11
(-33%)
Severe decline -20.0%, PE contracts to 20.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share VMD Analysis
Share this live VMD analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (VMD)
Bullish
2 Retail Mentions
StockTwits Volume
2 msgs
24h retail stream
Last Tracked
Jul 5, 2026
Daily AI digest
AI Retail Discussion Summary:
Traders on StockTwits express optimistic sentiment towards $VMD, with some referencing specific events and lucky numbers. No recent news articles were found.
Key Retail Themes:
Positive sentiment towards $VMD
References to specific events and lucky numbers
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 8:10 PM ET
Data refreshes hourly during market hours. Next update: 9:10 PM
Data refreshes hourly during market hours. Next update: 9:10 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$98 | 52 HOLD |
|
BSX
Boston Scientific Corp |
BUY
31 analysts |
$50 | 53 HOLD |
|
MDT
Medtronic PLC |
BUY
30 analysts |
$105 | 39 SELL |
|
PODD
Insulet Corporation |
BUY
26 analysts |
$178 | 45 HOLD |
|
TNDM
Tandem Diabetes Care Inc |
BUY
25 analysts |
$28 | 49 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive VMD Research Pages
